Login
Cart
Support
Search
Search
Search
Choon Hyuck David Kwon
Appearances
View Grid
NEOADJUVANT THERAPY REDUCES NODE POSITIVITY BUT DOES NOT CONFER SURVIVAL BENEFIT VERSUS UP-FRONT RESECTION FOR RESECTABLE INTRAHEPATIC CHOLANGIOCARCINOMA: A PROPENSITY-MATCHED ANALYSIS
Date
May 21, 2024
Intrahepatic Cholangiocarcinoma (iCCA) is rare but deadly. Neoadjuvant systemic therapy (NAST) is frequently employed, though its’ impact on short-term oncologic outcomes and/or survival remains relatively unknown…
Presenter
Chase Wehrle
Speakers
Jenny Chang
Kimberly Woo
Abby Gross
Robert Naples
Kathryn Stackhouse
Jaekeun Kim
Toms Augustin
Cleveland Clinic
Robert Simon
Daniel Joyce
Choon Hyuck David Kwon
R Matthew Walsh
Cleveland Clinic
Federico Aucejo
Cleveland Clinic
Samer Naffouje